{"favorite_id": 3907, "calc_type": "", "dosing": false, "full_title_en": "Pediatric Crohn\u2019s Disease Activity Index (PCDAI)", "short_title_en": "PCDAI Score", "medium_description_en": "Stratifies severity of Crohn\u2019s disease in pediatric patients.", "short_description_en": "Pediatric Crohn\u2019s severity.", "before_use": "", "instructions_en": "<p>Use in patients \u226419 years old.</p>", "purpose_en": ["Prognosis"], "disease_en": ["Crohn's Disease", "Inflammatory Bowel Disease"], "specialty_en": ["Family Practice", "Gastroenterology", "Pediatrics"], "chief_complaint_en": ["Abdominal Pain", "Diarrhea"], "system_en": ["Gastrointestinal"], "search_abbreviation_en": ["Peds", "cd", "crohns", "bowel", "IBD", "crohns disease"], "slug": "pediatric-crohns-disease-activity-index-pcdai", "seo": {"meta_description_en": "Pediatric Crohn\u2019s Disease Activity Index (PCDAI) determines severity of Crohn\u2019s Disease in pediatric patients.", "keywords_en": "Peds, CD, crohns, bowel, crohn\u2019s disease, crohn\u2019s peds, cd peds, pediatric crohns disease, crohns disease"}, "content": {"how_to_use": {"use_case_en": "<ul> <li>Patients \u226419 years old with confirmed diagnosis of Crohn\u2019s disease.</li> <li>Can be used in initial or follow-up visits to assess and track severity.</li> </ul>", "pearls_pitfalls_en": "<ul> <li>The Pediatric Crohn\u2019s Disease Activity Index (PCDAI) was developed to stratify severity of Crohn\u2019s disease in pediatric patients.</li> <li>Maximum possible score is 100, and each decrease in score by 12.5 points indicates clinically significant response to therapy.</li> <li>Symptom scores are based on recall from the previous week.</li> <li>Calculate weight based on previous measurement at least 4\u20136 months earlier.</li> <li>Perianal skin tags alone do not add to the \u201cPerirectal disease\u201d component of the score. There must be additional findings such as drainage, tenderness, or fistula.</li> <li>Height is scored differently for initial visits versus follow-up visits. At initial visit, height should be compared against percentile prior to the onset of symptoms. On follow-up, height velocity should be calculated based on a value from the previous 6\u201312 months.</li> </ul>", "why_use_en": "<ul> <li>Combines essential subjective information, examination findings, and labs into a single score.</li> <li>Commonly used in research to help assess treatment outcomes.</li> </ul>"}, "next_steps": {"advice_en": "<p>Note that hematocrit parameters differ based on age and sex.</p>", "management_en": "<ul> <li>Increasing score should prompt consideration of further evaluation or change in therapy.</li> <li>If score is abnormal in subjective components only, it is possible that functional abdominal pain, rather than Crohn\u2019s disease, is responsible.</li> </ul>", "critical_actions_en": ""}, "about": {"formula_en": "<p>Addition of the selected points:</p> <table> <tbody> <tr> <td colspan=\"4\"> <p><strong>History (based on recall within the previous week)</strong></p> </td> </tr> <tr> <td>&nbsp;</td> <td> <p><strong>0 points</strong></p> </td> <td> <p><strong>5 points</strong></p> </td> <td> <p><strong>10 points</strong></p> </td> </tr> <tr> <td> <p><strong>Abdominal pain</strong></p> </td> <td> <p>None</p> </td> <td> <p>Mild (brief, does not interfere with activities)</p> </td> <td> <p>Moderate to severe (daily, longer lasting, affects activities, or nocturnal pain)</p> </td> </tr> <tr> <td> <p><strong>Stools per day</strong></p> </td> <td> <p>0\u20131 liquid stools, no blood</p> </td> <td> <p>Up to 2 semi-formed stool with small blood, or 2\u20135 liquid stools</p> </td> <td> <p>Gross bleeding or \u22656 liquid stools, or nocturnal diarrhea</p> </td> </tr> <tr> <td> <p><strong>General well-being</strong></p> </td> <td> <p>Well (no limitation of activities)</p> </td> <td> <p>Below par (occasional difficulty in maintaining age-appropriate activities)</p> </td> <td> <p>Very poor (frequent limitation of activity)</p> </td> </tr> <tr> <td colspan=\"4\"> <p><strong>Examination</strong></p> </td> </tr> <tr> <td>&nbsp;</td> <td> <p><strong>0 points</strong></p> </td> <td> <p><strong>5 points</strong></p> </td> <td> <p><strong>10 points</strong></p> </td> </tr> <tr> <td> <p><strong>Weight</strong></p> </td> <td> <p>Weight gain, weight voluntarily stable, or voluntary weight loss</p> </td> <td> <p>Weight involuntarily stable or weight loss 1\u20139%</p> </td> <td> <p>Weight loss \u226510%</p> </td> </tr> <tr> <td> <p><strong>Height*</strong></p> </td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td> <p>At diagnosis, or</p> </td> <td> <p>&lt;1 channel decrease</p> </td> <td> <p>1 \u2264 channel decrease &lt; 2</p> </td> <td> <p>\u22652 channel decrease</p> </td> </tr> <tr> <td> <p>At follow-up</p> </td> <td> <p>Height velocity \u2265-1SD</p> </td> <td> <p>-1SD &gt; height velocity &gt; -2SD</p> </td> <td> <p>Height velocity \u2264-2SD</p> </td> </tr> <tr> <td> <p><strong>Abdomen</strong></p> </td> <td> <p>No tenderness, no mass</p> </td> <td> <p>Tenderness, or mass without tenderness</p> </td> <td> <p>Tenderness, involuntary guarding, or definite mass</p> </td> </tr> <tr> <td> <p><strong>Peri-rectal disease</strong></p> </td> <td> <p>None or asymptomatic tags</p> </td> <td> <p>1\u20132 indolent fistulae, scant drainage, and no tenderness</p> </td> <td> <p>Active fistula, drainage, tenderness, or abscess</p> </td> </tr> <tr> <td> <p><strong>Extra-intestinal manifestations: </strong>Fever \u226538.5\u00baC (101.3\u00baF) for 3 days over past week, definite arthritis, uveitis, erythema nodosum, or pyoderma gangrenosum</p> </td> <td> <p>None</p> </td> <td> <p>1</p> </td> <td> <p>\u22652</p> </td> </tr> <tr> <td colspan=\"4\"> <p><strong>Laboratory</strong></p> </td> </tr> <tr> <td>&nbsp;</td> <td> <p><strong>0 points</strong></p> </td> <td> <p><strong>2.5 points</strong></p> </td> <td> <p><strong>5 points</strong></p> </td> </tr> <tr> <td> <p><strong>Hematocrit, %</strong></p> </td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr> <td> <p>&lt;10 years</p> </td> <td> <p>&gt;33</p> </td> <td> <p>28\u201332</p> </td> <td> <p>&lt;28</p> </td> </tr> <tr> <td> <p>Female, 11\u201319 years</p> </td> <td> <p>\u226534</p> </td> <td> <p>29\u201333</p> </td> <td> <p>&lt;29</p> </td> </tr> <tr> <td> <p>Male, 11\u201314 years</p> </td> <td> <p>\u226535</p> </td> <td> <p>30\u201334</p> </td> <td> <p>&lt;30</p> </td> </tr> <tr> <td> <p>Male, 15\u201319 years</p> </td> <td> <p>\u226537</p> </td> <td> <p>32\u201336</p> </td> <td> <p>&lt;32</p> </td> </tr> <tr> <td> <p><strong>ESR, mm/hr</strong></p> </td> <td> <p>&lt;20</p> </td> <td> <p>20\u201350</p> </td> <td> <p>&gt;50</p> </td> </tr> <tr> <td>&nbsp;</td> <td> <p><strong>0 points</strong></p> </td> <td> <p><strong>5 points</strong></p> </td> <td> <p><strong>10 points</strong></p> </td> </tr> <tr> <td> <p><strong>Albumin, g/dL (g/L)</strong></p> </td> <td> <p>\u22653.5 (35)</p> </td> <td> <p>3.1\u20133.4 (31\u201334)</p> </td> <td> <p>\u22643.0 (30)</p> </td> </tr> </tbody> </table> <p>&nbsp;Height velocity can be referenced <a href=\"https://prokiids.com/uploads/Height_Velocity_Z_Score_Ref.pdf\" target=\"_blank\">here</a>.</p>", "more_info_en": "<p><strong>Interpretation</strong>:</p> <table> <tbody> <tr> <td> <p><strong>PCDAI</strong></p> </td> <td> <p><strong>Severity</strong></p> </td> </tr> <tr> <td> <p>&lt;10</p> </td> <td> <p>Remission</p> </td> </tr> <tr> <td> <p>10\u201327.5</p> </td> <td> <p>Mild Crohn\u2019s Disease</p> </td> </tr> <tr> <td> <p>30\u201337.5</p> </td> <td> <p>Moderate Crohn\u2019s Disease</p> </td> </tr> <tr> <td> <p>\u226540</p> </td> <td> <p>Severe Crohn\u2019s Disease</p> </td> </tr> </tbody> </table> <p>From <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/20372111\" target=\"_blank\">Turner 2010</a>, <em>American Journal of Gastroenterology</em>.</p>", "evidence_based_medicine_en": "<p>The PCDAI was developed by a group of 30 pediatric gastroenterologists with extensive experience in inflammatory bowel disease (IBD) management.</p> <p>The paper by <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/1678008\" target=\"_blank\">Hyams et al</a> initially describing the score compared scores for 133 patients against both physician global assessment, as well as the modified Harvey-Bradshaw Index (which includes only subjective and exam data) finding strong agreement with both. Interobserver agreement was strong as well.</p> <p>A follow up study by <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/10029610\" target=\"_blank\">Otley et al</a> found that PCDAI performed better at discriminating levels of disease activity, compared against the adult-oriented <calculator id=\"2177\">Crohn\u2019s Disease Activity Index</calculator> (CDAI).</p> <p>A decrease in score by 12.5 points was found to be optimal for detecting a clinically significant response to therapy (<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/20372111\" target=\"_blank\">Turner et al</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12500001\" target=\"_blank\">Kundhal et al</a>). &nbsp;The PCDAI has been found to be responsive to improvement over intervals as short as 4 weeks.</p> <p>A subsequent prospective validation study (<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/16205508\" target=\"_blank\">Hyams et al 2005</a>) confirmed that changes in PCDAI match with Physician Global Assessment over time. &nbsp;This study helped to clarify which scores corresponded to levels of disease severity (see Facts &amp; Figures).</p>", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/1678008", "text": "Hyams JS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991 May;12(4):439-47."}], "Other References": [], "Validation": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/16205508", "text": "Hyams J, et al. Evaluation of the pediatric Crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr. 2005 Oct;41(4):416-21."}], "Clinical Practice Guidelines": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/20372111", "text": "Turner D, Griffiths AM, Walters TD, et al. Appraisal of the pediatric Crohn's disease activity index on four prospectively collected datasets: recommended cutoff values and clinimetric properties. Am J Gastroenterol. 2010;105(9):2085-92."}], "Manufacturer Website": [], "Outcomes": []}}, "contributor": {"expert_name": [{"description": "", "firstName": "Peter", "img": "", "lastName": "Townsend", "name": "Peter Townsend, MD", "target": "", "signedCOI": true, "hasDisclosure": []}]}, "creator": [{"name": "Dr. Jeffrey Hyams", "qa_en": "", "creator_info": {"about_en": "<p>Jeffrey Hyams, MD, is a professor of pediatrics at the University of Connecticut School of Medicine. He currently serves on the Rome Committee, an international research organization that investigates the course and treatment of functional GI disorders. Dr. Hyams' research focuses on pediatric digestive diseases, and he is a co-author of <i>Pediatric Gastrointestinal and Liver Disease</i>, now in its 5th edition.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-jeffrey-hyams.jpeg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Hyams+JS%5BAuthor%5D"}}], "reviewer": {"expert_name": []}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"subheading": "History: Based on recall from the previous week", "subheading_instructions": "", "type": "subheading"}, {"type": "radio", "label_en": "Abdominal pain", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "None", "value": 0}, {"label": "Mild: Does not interfere with activities", "value": 5}, {"label": "Moderate/Severe: Daily, longer lasting, affects activities, nocturnal", "value": 10}], "name": "ap"}, {"type": "radio", "label_en": "Stools per day", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "0\u20131 liquid stools, no blood", "value": 0}, {"label": "2-5 liquid or \u22642 semi-formed with small blood", "value": 5}, {"label": "\u22656 liquid, gross blood, or nocturnal diarrhea", "value": 10}], "name": "stools"}, {"type": "radio", "label_en": "General well-being", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "Well (no limitation of activities)", "value": 0}, {"label": "Below par (occasional difficulty in maintaining age-appropriate activities)", "value": 5}, {"label": "Very poor (frequent limitation of activity)", "value": 10}], "name": "func"}, {"subheading": "Examination", "subheading_instructions": "", "type": "subheading"}, {"type": "radio", "label_en": "Weight", "default": 0, "conditionality": "", "show_points": true, "tips_en": "Based on previous measurement at least 4-6 months earlier", "optional": false, "options": [{"label": "Weight gain, weight voluntarily stable, or voluntary weight loss", "value": 0}, {"label": "Weight involuntarily stable or weight loss 1\u20139%", "value": 5}, {"label": "Weight loss \u226510%", "value": 10}], "name": "wt"}, {"type": "radio", "label_en": "Height at diagnosis (or at follow-up)", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "<1 channel decrease (or height velocity \u2265 -1SD)", "value": 0}, {"label": "Channel decrease \u22651 and <2 (or height velocity <-1SD and >-2SD)", "value": 5}, {"label": "\u22652 channel decrease (or height velocity \u2264-2SD)", "value": 10}], "name": "ht"}, {"type": "radio", "label_en": "Abdomen", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No tenderness, no mass", "value": 0}, {"label": "Tenderness, or mass without tenderness", "value": 5}, {"label": "Tenderness, involuntary guarding, or definite mass", "value": 10}], "name": "abd"}, {"type": "radio", "label_en": "Peri-rectal disease", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "None or asymptomatic tags", "value": 0}, {"label": "1\u20132 indolent fistulae, scant drainage, and no tenderness", "value": 5}, {"label": "Active fistula, drainage, tenderness, or abscess", "value": 10}], "name": "peri"}, {"type": "radio", "label_en": "Extra-intestinal manifestations", "default": 0, "conditionality": "", "show_points": true, "tips_en": "Fever \u226538.5\u00baC (101.3\u00baF) for 3 days over past week, arthritis, uveitis, erythema nodosum, or pyoderma gangrenosum", "optional": false, "options": [{"label": "None", "value": 0}, {"label": "1", "value": 5}, {"label": "\u22652", "value": 10}], "name": "intest"}, {"subheading": "Laboratory", "subheading_instructions": "", "type": "subheading"}, {"type": "toggle", "label_en": "Sex", "default": null, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "Male", "value": 0}, {"label": "Female", "value": 1}], "name": "sex"}, {"label_en": "Age", "conditionality": "", "default": null, "tips_en": "", "optional": false, "name": "age", "unit": "age_pas", "type": "textbox", "unit_info": {"name": "Age", "conversion": 1, "error_min": 2, "error_max": 19, "warn_min": 2, "warn_max": 19, "normal_max_si": 0, "normal_min_si": 0, "normal_min_us": 0, "units_si": "years", "units_us": "years"}}, {"label_en": "Hematocrit", "conditionality": "", "default": null, "tips_en": "", "optional": false, "name": "hct", "unit": "hct", "type": "textbox", "unit_info": {"name": "Hematocrit", "conversion": 1, "error_min": 1, "error_max": 70, "warn_min": 20, "warn_max": 55, "normal_max_si": 51, "normal_min_si": 36, "normal_min_us": 36, "units_si": "%", "units_us": "%", "normal_max_us": 51}}, {"label_en": "ESR", "conditionality": "", "default": null, "tips_en": "", "optional": false, "name": "esr", "unit": "esr", "type": "textbox", "unit_info": {"name": "CRP", "conversion": 1, "error_min": 0, "error_max": 100, "warn_min": 0, "warn_max": 50, "normal_max_si": 20, "normal_min_si": 0, "normal_min_us": 0, "units_si": "mm/hr", "units_us": "mm/hr", "normal_max_us": 20}}, {"label_en": "Albumin", "conditionality": "", "default": null, "tips_en": "", "optional": false, "name": "alb", "unit": "alb", "type": "textbox", "unit_info": {"name": "Albumin", "conversion": 10, "error_min": 0, "error_max": 7, "warn_min": 1, "warn_max": 6, "normal_max_si": 55, "normal_min_si": 35, "normal_min_us": 3.5, "units_si": "g/L", "units_us": "g/dL", "normal_max_us": 5.5}}], "md5": "", "related_calcs": [{"calcId": 10237, "short_title_en": "Montreal Classification for IBD", "slug": "montreal-classification-inflammatory-bowel-disease-ibd"}, {"calcId": 10069, "short_title_en": "Harvey-Bradshaw Index (HBI)", "slug": "harvey-bradshaw-index-hbi-crohns-disease"}, {"calcId": 3318, "short_title_en": "Crohn's Disease Activity Index (CDAI)", "slug": "crohns-disease-activity-index-cdai"}]}